Healthcare budget
The Centre on Friday approved Bharat Biotech’s needle-free intranasal Covid vaccine for booster dose, said an official source.
The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
The source said that Nasal vaccine will be used as a heterologous booster among eligible population. Meanwhile, the intranasal Covid vaccine is also expected to be introduced in the COVID19 vaccination program from today, said the source.
The nasal vaccine is likely to be added to the CoWIN App from today.
Meanwhile, India on Friday reported 163 fresh COVID-19 cases along with 9 deaths have also been reported in the country. The number of active coronavirus cases declines to 3,380.
In a ground-breaking medical achievement, Doctors at Fortis Escorts, Okhla, have successfully performed India's first…
A new study has revealed that letting your household dogs or pets lick on your…
Hair fall is something almost everyone experiences at some point. Whether you're noticing a few…
The Lancet Diabetes & Endocrinology Commission, a group of 58 leading experts from various medical…
Recently, an 8-year-old student of class 3 died due to cardiac arrest in her school…
Ahead of the Union Budget for the financial year 2025-26 to be presented by on…